Fierce Pharma

JANUARY 3, 2023

COVID-19 tracker: AstraZeneca workers who were fired for refusing vaccine file lawsuit. kdunleavy. Tue, 01/03/2023 - 10:31.

320

320

MedCity News

JANUARY 3, 2023

Withings announced that it is developing a miniaturized platform that can analyze urine at home. The device, called U-Scan, sits within a toilet bowl and assesses specific biomarkers found in urine.

Medical 135

Medical 135

Fierce Pharma

JANUARY 3, 2023

Lilly, Merck double down on peptide-targeted drug delivery, betting billions in biobucks on PeptiDream pacts. ntaylor. Tue, 01/03/2023 - 08:31.

236

236

MedCity News

JANUARY 3, 2023

We expect 2023 to be a pivotal year for the industry, as the accelerated acceptance of virtual care and demographic trends, such as an aging population, increasing chronic illnesses and healthcare worker shortages, sustain demand for medtech-enabled solutions.

Healthcare 120

Healthcare Healthcare 120

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

Fierce Pharma

JANUARY 3, 2023

Unicycive's pivotal trial of rival to Takeda kidney drug hits main goal, clearing path to FDA filing. ntaylor. Tue, 01/03/2023 - 03:20.

FDA 229

FDA 229

MedCity News

JANUARY 3, 2023

A recent study published in BMC Psychiatry found that depression and anxiety decreased at similar rates between patients using telehealth and patients receiving in-person care.

Patients 113

Patients 113

PharmaVoice

JANUARY 3, 2023

Durect’s chief medical officer altered his retirement plans to take a leading role at the company, which is developing a treatment for severe alcohol-associated hepatitis.

Leads 111

Leads Medical 111

Healthcare Success

JANUARY 3, 2023

I’ve noticed that most people tend to focus on only one of four variables when optimizing their digital marketing results. That’s a shame because true optimization requires a more strategic approach that considers each of the following four factors: Consumer Demand. Campaign Management (e.g., Google Ads or Microsoft). Landing Page. Conversion Process.

Marketing 108

Marketing Management Training Relationship management 108

PharmaTech

JANUARY 3, 2023

Advancing the use of AI to understand the whole of a disease can reveal drug development insights that lead to drug discovery breakthroughs.

Leads 122

Leads 122

pharmaphorum

JANUARY 3, 2023

Encouraged by new data, Newron Pharmaceuticals has said it will start a registration study of would-be blockbuster evenamide in treatment-resistant schizophrenia (TRS) later this year. The Italian biopharma said it had decided to press ahead with the new study after assessing results from 100 patients with TRS in open-label studies who received the glutamate modulator drug as an add-on to their current therapy for more than six months.

Side effects 105

Side effects Biopharma Patients Competition 105

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

JANUARY 3, 2023

As macroeconomic forces continue to negatively impact the healthcare sector, health tech experts predict that 2023 will be another slow year for the IPO market. However, they think consolidation deals will continue to be a constant, according to a new report.

Healthcare 104

Healthcare Healthcare Marketing 104

pharmaphorum

JANUARY 3, 2023

Research advises against aggressive cancer treatment at the end-of-life stages of the disease. At the same time, the pharmaceutical industry is creating a greater number of oncology treatments that could provide breakthroughs for patients where none previously existed. Ben Hargreaves examines why there is no easy answer to the question of when palliative care is the right option for patients.

Healthcare 105

Healthcare Healthcare Patients Side effects 105

Clarivate

JANUARY 3, 2023

To highlight fast-moving and emerging specialty areas of science, Clarivate has once again partnered with the Chinese Academy of Science (CAS) on a special report on the hottest fields in science, including data on the regions and institutions producing the work. The latest annual edition, Research Fronts 2022, marks the 9th collaboration between Clarivate and the CAS.

Specialization 98

Specialization Side effects Management Medicine 98

MedCity News

JANUARY 3, 2023

Gilead Sciences is building up its autoimmune disease drug pipeline by turning to EVOQ Therapeutics, a startup with technology that takes a novel approach to restoring immune tolerance. For EVOQ, the Gilead deal is its second with a big pharma company.

Pharma 98

Pharma Biopharma 98

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

Pharma Pathway

JANUARY 3, 2023

Lupin Limited- Walk-In Interview for Quality Assurance Dept. On 7th Jan’ 2023. Job Description. Lupin Limited is an Indian Multinational pharmaceutical Company based in Mumbai, Maharashtra, India. It is one of the largest generic pharmaceutical Companies by revenue globally. The Company’s key focus areas include paediatrics, Cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.

Education 91

Education Pharmaceutical Pharma 91

MedCity News

JANUARY 3, 2023

Atacicept, a Vera Therapeutics drug in development for the rare kidney disease immunoglobulin A nephropathy, is on its way to a pivotal test after achieving the main goal of a mid-stage clinical trial. But the results still fall short of data recently reported by a competitor that is addressing the same disease target.

Biopharma 98

Biopharma Pharma 98

Pharma Pathway

JANUARY 3, 2023

Lupin Limited- Walk-In Interview for Freshers & Experienced in Production Dept. On 7th Jan’ 2023. Job Description. Walk-In Interview for M.Sc/ B.Sc/ Diploma in Production- API @ Vadodara, Gujarat. Lupin Limited is an Indian Multinational pharmaceutical Company based in Mumbai, Maharashtra, India. It is one of the largest generic pharmaceutical Companies by revenue globally.

Education 88

Education Pharmaceutical Pharma 88

MedCity News

JANUARY 3, 2023

Possible strategies for employers to reduce disparities include addressing social determinants of health, improving care navigation, leveraging virtual care and upgrading plan offerings, the authors of a Harvard Business Review report said.

96

96

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

European Pharmaceutical Review

JANUARY 3, 2023

A marketing authorisation application (MAA) has been submitted by The Janssen Pharmaceutical Companies of Johnson & Johnson to the European Medicines Agency (EMA) for approval of talquetamab, a bispecific t-cell engager antibody for the treatment of patients with relapsed or refractory multiple myeloma (RRMM). Talquetamab is an investigational, off-the-shelf treatment targeting both GPRC5D, a novel drug target that is on some normal cells but overexpressed on myeloma cells, and CD3 on t-cell

Marketing 80

Marketing Food and Drug Administration Medicine Food 80

MedCity News

JANUARY 3, 2023

By allowing study teams to design and conduct more inclusive and/or relevant studies, real-world data can enhance the standard of care and ultimately improve patient outcomes.

Recruitment 96

Recruitment Leads Patients Biopharma 96

Pharma Pathway

JANUARY 3, 2023

Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 7th Jan’ 2023. Job Description. Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceutical manufacturing firm with turnover of over US$2.8 Billion revenues for 2018-19, with presence in more than 34 countries fronted presence with products exported to 155 nations.

Pharma 75

Pharma Pharmaceutical manufacturing Manufacturing Education 75

MedReps

JANUARY 3, 2023

The importance of a sales pitch can’t be overlooked, as it is crucial for introducing your products to customers and making those sales. While sales pitches need to include a number of different things, including hitting customers’ pain points, explaining more about the products and ending with an open-ended statement designed to further conversation, there are a number of questions that can be added in as well.

Medical sales reps 73

Medical sales reps Medical sales Sales Sales pitches 73

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management

Copyright Clearance Center

JANUARY 3, 2023

The post Can I Get My Favorite Song Here? A Lesson About Music Libraries appeared first on Copyright Clearance Center.

98

98

Pharma Pathway

JANUARY 3, 2023

Cipla- Openings for Multiple Positions in Engineering -Apply Now. Job Description. Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression. Career at Cipla. Desired Profile: Career Opportunity for multiple roles in Engineering at Cipla Bangalore.

Engineering 71

Engineering Management Medicine Pharmaceutical 71

PharmaTimes

JANUARY 3, 2023

Company has reported booster details from a study of its inactivated COVID-19 candidate

100

100

pharmaphorum

JANUARY 3, 2023

Suzhou-based CStone Pharmaceuticals’ checkpoint inhibitor sugemalimab has proved effective in a trial as a first-line therapy for oesophageal cancer, setting up a regulatory filing in China. The Hong Kong-listed cancer biotech said this morning that anti-PD-L1 inhibitor sugemalimab given in combination with chemotherapy showed “statistically significant and clinically meaningful” improvements in both progression-free survival (PFS) and overall survival (OS) in previously-untrea

Pharmacology 59

Pharmacology Patients Marketing FDA 59

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

PharmaTimes

JANUARY 3, 2023

Second study will develop a bispecific antibody with potential applications in solid tumours

91

91

pharmaphorum

JANUARY 3, 2023

Catherine Isted has stepped down as chief executive of UK biotech ReNeuron with immediate effect, with board member and biopharma industry veteran Iain Ross appointed as executive chairman with a remit to revamp the business. The change at the top comes as ReNeuron is in the throes of a pivot in its business after years of stuttering progress with stem cell programmes and a perennial shortage of operating cash, with the company announcing in July it would concentrate efforts on a proprietary exo

Biopharma 59

Biopharma Pharma Leads Management 59

PharmaVoice

JANUARY 3, 2023

A preview of the top trends on the minds of industry and market leaders for the new year.

Marketing 83

Marketing 83

Pharma Pathway

JANUARY 3, 2023

Gland Pharma-Walk-In Interview for B.Sc, B.Pharm, M.Sc, M.Pharm in Production Department 6th Jan’ 2023. Job Description. Walk-in for experienced for Production candidates on 6th January 2023 (Friday) @ Gland Pharma Unit 1, Pashamylaram | Experience: 1-7 years | Immediate Joiners Preferred | Parenteral Experience Mandatory|. Production: Hands on experience in Vial, Ampoule, Aseptic Area Filling/ Vial Sealing/ Line Chemist/ Compounding/ Autoclave operators.

Pharma 62

Pharma Education Management 62

Advertisement

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

Patients